儿童溶血性尿毒症综合征的心脏表现与住院死亡风险
该回顾性多中心队列研究基于2004-2018年Pediatric Health Information System数据库,纳入3915例≤18岁溶血性尿毒症综合征患儿,其中6.1%出现心脏表现。任何心脏表现均与住院死亡风险升高相关(OR 9.74),≥2种心脏病变、心脏骤停或使用ECMO者死亡风险更高。
要点
- 溶血性尿毒症综合征患儿中6.1%出现心脏表现,以心包疾病最常见。
- ≥2种心脏病变、心脏骤停或ECMO部署与更高住院死亡风险相关。
核心结论
- 儿童溶血性尿毒症综合征患者中,心脏表现类型不同,住院死亡风险存在差异。
- 多重心臓受累、心脏骤停和体外膜肺氧合(ECMO)部署与住院死亡风险升高相关。
研究设计与样本
- 回顾性、多中心队列研究,使用Pediatric Health Information System数据库。
- 纳入2004-2018年≤18岁儿童中首次溶血性尿毒症综合征相关住院 Visit,共3915例。
主要发现
- 3915例患者中238例(6.1%)出现心脏表现,其中82.8%(197例)有1种心脏疾病,17.2%(41例)有≥2种心脏疾病。
- 最常见的心脏疾病为心包疾病(102例),其次为充血性心力衰竭(46例)和心肌病/心肌炎(34例)。
- 无心脏疾病、有1种心脏疾病和≥2种心脏疾病患者的死亡率分别为2.1%、17.3%和19.5%。
关键数值与推荐
- 心脏表现定义为心包疾病、充血性心力衰竭、心肌病/心肌炎、心脏骤停或ECMO部署等。
- 死亡风险比较以无心脏疾病患者为参照。
临床怎么用
- 对溶血性尿毒症综合征患儿应评估心脏表现,尤其是心包疾病、心力衰竭和心肌病/心肌炎。
- 出现任何心脏表现、多重心臓受累、心脏骤停或需要ECMO的患儿住院死亡风险显著升高,需加强监护。
局限性
- 回顾性研究设计可能受编码数据准确性限制。
- 仅纳入Pediatric Health Information System数据库中的住院 Visit,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The primary objectives of the study were to describe the association between cardiac manifestations and in-hospital mortality among children with hemolytic uremic syndrome. STUDY DESIGN: Using the Pediatric Health Information System database, this retrospective, multicenter, cohort study identified the first hemolytic uremic syndrome-related inpatient visit among children ≤18 years (years 2004-2018). The frequency of selected cardiac manifestations and mortality rates were calculated. Multivariate analysis identified the association of specific cardiac manifestations and the risk of in-hospital mortality. RESULTS: Among 3915 patients in the analysis, 238 (6.1%) had cardiac manifestations. A majority of patients (82.8%; n = 197) had 1 cardiac condition and 17.2% (n = 41) had ≥2 cardiac conditions. The most common cardiac conditions was pericardial disease (n = 102), followed by congestive heart failure (n = 46) and cardiomyopathy/myocarditis (n = 34). The percent mortality for patients with 0, 1, or ≥2 cardiac conditions was 2.1%, 17.3%, and 19.5%, respectively. Patients with any cardiac condition had an increased odds of mortality (OR, 9.74; P = .0001). In additional models, the presence of ≥2 cardiac conditions (OR, 9.90; P < .001), cardiac arrest (OR, 38.25; P < .001), or extracorporeal membrane oxygenation deployment (OR, 11.61; P < .001) were associated with increased risk of in-hospital mortality. CONCLUSIONS: This study identified differences in in-hospital mortality based on the type of cardiac manifestations, with increased risk observed for patients with multiple cardiac involvement, cardiac arrest, and extracorporeal membrane oxygenation deployments.
引用
- Sanders E, Brown CC, Blaszak RT, et al. Cardiac Manifestation among Children with Hemolytic Uremic Syndrome. J Pediatr. 2021. PMID: 33819463. doi:10.1016/j.jpeds.2021.03.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。